Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Arnsberg – page 19

222 clinical trials in Arnsberg, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Arnsberg at a glance
222
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

222 trials in Arnsberg

Open in trial search

Study on Decitabine, Venetoclax, and Tretinoin for Patients with Acute Myeloid Leukemia Who Cannot Have Induction Chemotherapy

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Medical Center - University Of Freiburg

Plasma cell myeloma

Not recruiting

Study on Elotuzumab, Carfilzomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carfilzomib
  • Sponsor:Universitaetsklinikum Wuerzburg AöR

Study on Brigatinib, Ceritinib, and Alectinib for Patients with Advanced ALK+ Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Alectinib
  • Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH

Study on Imatinib and Chemotherapy Combination for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Crisantaspase
  • Sponsor:Universita Degli Studi Di Milano Bicocca

Study on Additional Chemotherapy with Osimertinib, Carboplatin, and Cisplatin for Patients with Advanced Non-Small Cell Lung Cancer and EGFR Mutation

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Goethe University Frankfurt

Study on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Ibrutinib
  • Sponsor:Klinikum Der Universitat Munchen AöR

Other cities in Germany

The busiest research cities in the country

All 505 cities in Germany

Clinical research in Arnsberg

What the registry says about research in the country

01 Breast Cancer Research

Clinical trials focusing on hormone receptor-positive HER2-negative breast cancer are exploring innovative combination therapies. These studies aim to evaluate treatment effectiveness in patients with locally advanced or metastatic disease.

  • Combination Therapy Assessment
  • Digital Side Effect Monitoring
  • Disease Progression Analysis

Research emphasizes personalized treatment approaches for different patient cohorts based on their prior treatment history and response patterns.

02 Advanced Cancer Treatment

Investigations into endocrine therapy combinations are being conducted to improve outcomes for patients with advanced breast cancer. The research evaluates treatment effectiveness across different patient populations.

  • Treatment Response Monitoring
  • Survival Analysis
  • Patient Stratification

Studies incorporate modern digital technologies to enhance patient care and monitor treatment outcomes.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.